3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
Rituximab
9
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
fludarabine phosphate
6
Cyclophosphamide
6
Etoposide
5
Tacrolimus
4
Mycophenolic Acid
4
Cyclosporine
4
Carboplatin
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Thiotepa
2
Melphalan
2
Lenalidomide
2
Ipilimumab
2
Dexamethasone
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bendamustine Hydrochloride
2
Antilymphocyte Serum
2
veliparib
1
sodium thiosulfate
1
pegfilgrastim
1
oblimersen
1
merphos
1
etoposide phosphate
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Intraocular Lymphoma
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.